Modeling heterogeneity in the assessment of treatment effects on tumor development while accounting for monotone dropout
From MaRDI portal
Publication:2089348
Recommendations
- Modeling antitumor activity by using a non-linear mixed-effects model
- Modeling antitumor activity in xenograft tumor treatment
- Modeling Tumor Growth with Random Onset
- Small-sample inference for incomplete longitudinal data with truncation and censoring in tumor xenograft models
- Latent subgroup analysis of a randomized clinical trial through a semiparametric accelerated failure time mixture model
Cites work
- scientific article; zbMATH DE number 4082773 (Why is no real title available?)
- scientific article; zbMATH DE number 1253515 (Why is no real title available?)
- A class of pattern-mixture models for normal incomplete data
- Bayesian dose-finding in two treatment cycles based on the joint utility of efficacy and toxicity
- Modeling the Drop-Out Mechanism in Repeated-Measures Studies
- Nested Generalized Linear Mixed Models: An Orthodox Best Linear Unbiased Predictor Approach
- Pattern-Mixture Models for Multivariate Incomplete Data
- Random effects Cox models: A Poisson modelling approach
This page was built for publication: Modeling heterogeneity in the assessment of treatment effects on tumor development while accounting for monotone dropout
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2089348)